{
  "meta": {
    "title": "11_Pheochromocytoma",
    "url": "https://brainandscalpel.vercel.app/11-pheochromocytoma-527bce6a.html",
    "scrapedAt": "2025-11-30T12:28:23.980Z"
  },
  "questions": [
    {
      "text": "The clinical triad of pheochromocytoma includes all of the following symptoms except:",
      "choices": [
        {
          "id": 1,
          "text": "Headache"
        },
        {
          "id": 2,
          "text": "Hypertension"
        },
        {
          "id": 3,
          "text": "Profuse sweating"
        },
        {
          "id": 4,
          "text": "Palpitation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical<strong> triad</strong> of <strong>pheochromocytoma</strong> includes the following&nbsp;<strong>symptoms</strong>:</p>\n<ul>\n<li>Headache</li>\n<li>Profuse sweating</li>\n<li>Palpitation (due to tachycardia)</li>\n</ul>\n<p>Hypertension is the most predominant<strong> sign</strong> of pheochromocytoma. Though <strong>intermittent</strong> <strong>hypertension</strong> is a classical feature, sustained hypertension is also common.</p><hr><h3>Related Pearl: Clinical features of Pheochromocytoma (By frequency of occurrence)</h3><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches &ndash; most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) &ndash; most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3159",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following would you not see in a patient with pheochromocytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Pallor"
        },
        {
          "id": 2,
          "text": "Postural hypotension"
        },
        {
          "id": 3,
          "text": "High hematocrit"
        },
        {
          "id": 4,
          "text": "Hypocalcemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hypercalcemia</strong> is seen in patients with <strong>pheochromocytoma</strong>, not hypocalcemia. This is&nbsp;due to the production of&nbsp;parathyroid hormone-related peptide (<strong>PTHrP</strong>) by the tumor.&nbsp;</p><hr><h3>Related Pearl: Clinical features of Pheochromocytoma (By frequency of occurrence)</h3><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches &ndash; most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) &ndash; most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3162",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with pheochromocytoma, which of the following clinical features is least likely to be present?",
      "choices": [
        {
          "id": 1,
          "text": "Weight loss"
        },
        {
          "id": 2,
          "text": "Pallor"
        },
        {
          "id": 3,
          "text": "Abdominal pain"
        },
        {
          "id": 4,
          "text": "Oliguria"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Polyuria</strong>, not oliguria is seen in patients with <strong>pheochromocytoma</strong>.&nbsp;</p>\n<p>Excess catecholamine levels in this condition can cause polyuria and polydipsia due to<strong>&nbsp;hyperglycemia</strong>.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Clinical features of Pheochromocytoma (By frequency of occurrence)</h3><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches &ndash; most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) &ndash; most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1065",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an associated finding that can be seen in patients with pheochromocytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Erythema multiforme"
        },
        {
          "id": 2,
          "text": "Café au lait spots"
        },
        {
          "id": 3,
          "text": "Vitiligo"
        },
        {
          "id": 4,
          "text": "Ash leaf macules"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Caf&eacute; au lait </strong>spots are&nbsp;seen in <strong>neurofibromatosis 1,</strong> which is a <strong>pheochromocytoma-</strong>associated syndrome.</p>\n<p>Pheochromocytoma-associated syndromes include the following:</p>\n<ul>\n<li>Neurofibromatosis type 1</li>\n<li>Multiple endocrine neoplasia type 2</li>\n<li>Von Hippel&ndash;Lindau syndrome</li>\n<li>Paraganglioma syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3173",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following parameters can help you diagnose a patient with a malignant pheochromocytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Capsular invasion"
        },
        {
          "id": 2,
          "text": "Number of mitotic spindles"
        },
        {
          "id": 3,
          "text": "Lymph node involvement"
        },
        {
          "id": 4,
          "text": "Cellular atypia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Malignant</strong> pheochromocytoma refers to tumors that have undergone&nbsp;<strong>metastasis</strong> to<strong> lymph nodes</strong> or distant sites<strong>.</strong></p>\n<p>They are <strong>histologically</strong> and biochemically the <strong>same</strong> as <strong>benign</strong> ones.&nbsp;Hence,&nbsp;typical histological criteria like cellular atypia, mitotic spindles, and capsular invasion&nbsp;are insufficient to confirm<strong>&nbsp;</strong>malignancy in pheochromocytomas.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3172",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following catecholamines would be elevated in a patient with extra-adrenal pheochromocytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Norepinephrine"
        },
        {
          "id": 2,
          "text": "Epinephrine"
        },
        {
          "id": 3,
          "text": "Metanephrines"
        },
        {
          "id": 4,
          "text": "Vanillylmandelic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Norepinephrine</strong> is exclusively secreted in patients with extra-adrenal pheochromocytoma.</p>\n<p>The <strong>PNMT</strong> (phenylethanolamine-<em>N</em>-methyl transferase) enzyme <strong>converts</strong> <strong>norepinephrine </strong>to<strong> epinephrine</strong>. This enzyme is <strong>absent</strong> in <strong>extra-adrenal</strong> sites. Hence, extra-adrenal pheochromocytomas secrete only norepinephrine and cannot secrete&nbsp;epinephrine.&nbsp;</p>\n<p>On the other hand, adrenal&nbsp;pheochromocytomas can secrete norepinephrine, epinephrine, and&nbsp;dopamine in varying amounts depending on the PNMT levels in the tumor.</p>\n<p><strong>Extra-adrenal</strong> pheochromocytomas or&nbsp;catecholamine-secreting paragangliomas are most commonly found in the abdomen. They commonly arise from the <strong>organ of Zuckerkandl.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3169",
      "difficulty": "medium"
    },
    {
      "text": "A 31-year-old woman is rushed to the ED with a severe headache and vomiting. Past history includes a total thyroidectomy for thyroid cancer 3 months ago. Her BP is 200/100 mm Hg and pulse is 110/min. On examination, a marfanoid habitus is noted along with the findings shown. Which of the following is likely to be predominantly elevated?",
      "choices": [
        {
          "id": 1,
          "text": "Norepinephrine"
        },
        {
          "id": 2,
          "text": "Epinephrine"
        },
        {
          "id": 3,
          "text": "Dopamine"
        },
        {
          "id": 4,
          "text": "Vanillylmandelic acid"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario with a history of thyroid cancer&nbsp;(likely medullary carcinoma)&nbsp;and the image showing <strong>mucosal neuromas</strong> points towards&nbsp;<strong>MEN2B</strong> syndrome. Her current presentation is suggestive of&nbsp;a <strong>pheochromocytoma</strong>. She is likely to have predominantly elevated levels of<strong>&nbsp;epinephrine </strong>and its metabolite,<strong> metanephrine.</strong>&nbsp;</p>\n<p>This is due to the <strong>higher expression</strong> of the <strong>PNMT</strong> enzyme associated with the mutations in MEN2 syndromes (both 2A and 2B). The higher levels of epinephrine result in a <strong>more symptomatic</strong> presentation.</p>\n<p>In contrast, <strong>low PNMT expression</strong> is seen in von-Hippel-Lindau (<strong>VHL</strong>) syndrome. This leads to a predominant elevation of norepinephrine and normetanephrine levels. It is less symptomatic compared to MEN2 syndrome.</p><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b07eb89d38e5471685152c4fa967d31c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3170",
      "difficulty": "medium"
    },
    {
      "text": "In a suspected case of pheochromocytoma, which of the following would you avoid while making a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "MRI scan"
        },
        {
          "id": 2,
          "text": "MIBG scan"
        },
        {
          "id": 3,
          "text": "Image-guided biopsy"
        },
        {
          "id": 4,
          "text": "Genetic testing"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Biopsy </strong>and<strong> FNAC </strong>should be<strong> avoided</strong>&nbsp;in patients with pheochromocytoma, as it is a highly<strong>&nbsp;vascular </strong>tumor.&nbsp;</p>\n<p>CT and MRI have similar sensitivity but <strong>T2-weighted MRI</strong> with gadolinium contrast is the optimal test for diagnosis. MIBG (metaiodobenzylguanidine) scintigraphy can be used to localize the tumor if both CT and MRI are negative.</p>\n<p>Genetic testing may be performed as nearly 40% of the tumors are associated with familial syndromes like VHL, neurofibromatosis, and MEN2.</p>\n<p>Note: In cases of <strong>malignant</strong> pheochromocytoma,&nbsp;<strong>biopsy</strong> may be indicated to confirm adrenal gland&nbsp;<strong>metastasis</strong>&nbsp;in other sites.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3176",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged male patient is being evaluated for recurrent episodes of palpitations, headaches, and profuse sweating. He was found to have elevated blood pressure readings on multiple occasions over the past 2 months. Which of the following tests has the highest sensitivity and specificity for the diagnosis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "MRI"
        },
        {
          "id": 2,
          "text": "24-hour urinary fractionated metanephrines"
        },
        {
          "id": 3,
          "text": "MIBG scintigraphy"
        },
        {
          "id": 4,
          "text": "Fractionated plasma metanephrines"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>pheochromocytoma.</strong> The measurement of<strong> 24-hour urinary fractionated metanephrines</strong>&nbsp;has both the <strong>highest specificity</strong> and <strong>sensitivity</strong> in the diagnosis of this condition.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>24-hour urinary fractionated metanephrines</strong></td>\n<td><strong>Plasma fractionated metanephrines</strong></td>\n</tr>\n<tr>\n<td>Sensitivity</td>\n<td>98%</td>\n<td>96-100%</td>\n</tr>\n<tr>\n<td>Specificity</td>\n<td>98%</td>\n<td>85-89%</td>\n</tr>\n<tr>\n<td>False positives</td>\n<td>Very rare</td>\n<td>Can occur due to drugs like levodopa, TCAs, &alpha;-blockers, &beta;-blockers, diuretics</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td>Collection of samples over 24 hours may be cumbersome</td>\n<td>Requires only a single blood sample. May be preferred in children.</td>\n</tr>\n<tr>\n<td>Uses</td>\n<td>Preferred first-line test as it is highly specific</td>\n<td>\n<p>Reserved for patients with a high index of suspicion like:</p>\n<ul>\n<li>Family history</li>\n<li>Genetic syndromes like MEN2</li>\n<li>Prior history of pheochromocytoma</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Imaging modalities like CT and MRI have a sensitivity of around 98-100% and specificity of&nbsp;70%.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3177",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the best method for detecting and localization of tumors associated with pheochromocytomas?",
      "choices": [
        {
          "id": 1,
          "text": "Abdominal CT"
        },
        {
          "id": 2,
          "text": "Fluorodopa-PET"
        },
        {
          "id": 3,
          "text": "MIBG scintigraphy"
        },
        {
          "id": 4,
          "text": "Abdominal MRI"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Among the given options, the&nbsp;<strong>fluorodopa-PET&nbsp;</strong>scan is the&nbsp;best method for detecting and localization of tumors associated with&nbsp;<strong>pheochromocytoma</strong>.</p>\n<p>If biochemical testing for pheochromocytoma is positive, an<strong>&nbsp;</strong>abdominal<strong> MRI&nbsp;</strong>must be performed first. If MRI is negative or if multiple tumors are suspected, the tumor can be localized by performing one of the following investigations:&nbsp;</p>\n<ul>\n<li>68 Ga-DOTATATE PET scan - most sensitive, <strong>gold standard&nbsp;</strong></li>\n<li>Fluorodopa and&nbsp;18F-fluorodeoxyglucose (FDG) PET scans - 97% sensitive</li>\n<li>MIBG scintigraphy - <strong>least sensitive </strong>(94%)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3179",
      "difficulty": "hard"
    },
    {
      "text": "A 45-year-old man presented with recurrent episodes of headache, palpitations, and sweating. His blood pressure at presentation was 180/100 mm Hg. Further testing revealed elevated urinary metanephrines. CT abdomen showed a right adrenal mass. What is the drug of choice for the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Labetalol"
        },
        {
          "id": 2,
          "text": "Nitroprusside"
        },
        {
          "id": 3,
          "text": "Phenoxybenzamine"
        },
        {
          "id": 4,
          "text": "Phentolamine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of&nbsp;<strong>pheochromocytoma.</strong>&nbsp;The drug of choice to control blood pressure prior to surgery is oral&nbsp;<strong>phenoxybenzamine&nbsp;</strong>at&nbsp;0.5&ndash;4 mg/kg of body weight.&nbsp;It is a non-specific<strong> &alpha;-blocker</strong> and is preferred due to its<strong> long action</strong> (3-4 days).</p>\n<p>Other&nbsp;&alpha;-blockers like oral&nbsp;<strong>prazosin</strong> and intravenous <strong>phentolamine</strong>&nbsp;have a shorter duration of action and can be used to manage<strong> paroxysms.&nbsp;</strong>IV phentolamine is also used for <strong>intra-operative</strong> management of BP.</p>\n<p>&alpha;-blockers are usually given for 7 days.&nbsp;Following this,&nbsp;<strong>&beta;-blockers</strong> are started, usually 2-3 days preoperatively. &beta;-blockers should <strong>never</strong> be started <strong>first</strong> because blockade of vasodilatory peripheral &beta;-receptors with unopposed &alpha;-receptor stimulation can lead to a further elevation in blood pressure. (Mnemonic: A before B)</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3180",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following should not be used for the initial management, in a patient with pheochromocytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Prazosin"
        },
        {
          "id": 2,
          "text": "Atenolol"
        },
        {
          "id": 3,
          "text": "Nitroprusside"
        },
        {
          "id": 4,
          "text": "Metyrosine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Beta-blockers</strong> like atenolol should never be used as the initial drug or alone in the management of pheochromocytoma.</p>\n<p>They must be given only <strong>after</strong> adequate <strong>alpha blockade</strong> has been established. Blocking beta-receptors may cause unopposed stimulation of alpha-receptors, precipitating a hypertensive crisis.</p>\n<p>&nbsp;</p><p>Option A: Prazosin is an alpha-blocker.</p>\n<p>Option C: Nitroprusside can be used in case of hypertensive emergencies.</p>\n<p>Option D: Metyrosine inhibits catecholamine synthesis. It can be used when other agents have been ineffective.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3182",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a part of Averbuch’s chemotherapy protocol?",
      "choices": [
        {
          "id": 1,
          "text": "Dacarbazine"
        },
        {
          "id": 2,
          "text": "Vinblastine"
        },
        {
          "id": 3,
          "text": "Cyclophosphamide"
        },
        {
          "id": 4,
          "text": "Vincristine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Vinblastine is not included in Averbuch&rsquo;s chemotherapy protocol&nbsp;for the treatment of malignant pheochromocytoma.</p><hr><h3>Related Pearl: Averbuch’s Chemotherapy Protocol for Malignant Pheochromocytoma</h3><ul>\n<li><strong>Averbuch&rsquo;s chemotherapy protocol</strong> for malignant pheochromocytoma includes\n<ul>\n<li><strong>Dacarbazine </strong>(600 mg/m<sup>2 </sup>on days 1 and 2)</li>\n<li><strong>Cyclophosphamide</strong> (750 mg/m<sup>2</sup> on day 1)</li>\n<li><strong>Vincristine</strong> (1.4 mg/m<sup>2 </sup>on day 1)</li>\n</ul>\n</li>\n<li>All repeated <strong>every 21 days</strong> for three to six cycles.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3184",
      "difficulty": "medium"
    },
    {
      "text": "A patient is diagnosed with malignant pheochromocytoma. Which of the following is used to treat this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Strontium"
        },
        {
          "id": 2,
          "text": "Cobalt-60"
        },
        {
          "id": 3,
          "text": "Phosphorus"
        },
        {
          "id": 4,
          "text": "MIBG"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong><sup>131</sup>I-MIBG </strong>(metaiodobenzylguanidine)<strong>&nbsp;</strong>is used for the <strong>treatment</strong> of&nbsp;<strong>malignant pheochromocytoma</strong>.</p>\n<p>Malignant pheochromocytomas occur in 10% of cases and are histologically and biochemically the same as benign ones. The diagnosis of malignant pheochromocytoma is based on documentation of metastatic disease.&nbsp;The treatment of choice is <strong>nuclear medicine</strong> therapy with any of the following:</p>\n<ul>\n<li><sup>1</sup><sup>31</sup>I-MIBG at 200-mCi doses at monthly intervals (3-6 cycles)</li>\n<li><strong>DOTATOC</strong> (a somatostatin receptor analog) labeled with radioactive lutetium or yttrium</li>\n</ul>\n<p>Chemotherapy can also be given according to Averbuch's protocol.</p>\n<p>Note: <sup>123</sup>I-MIBG and Gallium-DOTATATE are used for imaging.</p><hr><h3>Related Pearl: Averbuch’s Chemotherapy Protocol for Malignant Pheochromocytoma</h3><ul>\n<li><strong>Averbuch&rsquo;s chemotherapy protocol</strong> for malignant pheochromocytoma includes\n<ul>\n<li><strong>Dacarbazine </strong>(600 mg/m<sup>2 </sup>on days 1 and 2)</li>\n<li><strong>Cyclophosphamide</strong> (750 mg/m<sup>2</sup> on day 1)</li>\n<li><strong>Vincristine</strong> (1.4 mg/m<sup>2 </sup>on day 1)</li>\n</ul>\n</li>\n<li>All repeated <strong>every 21 days</strong> for three to six cycles.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3187",
      "difficulty": "medium"
    }
  ]
}